EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Revolutionizing vaccination: the marvel of nanovaccination technology

Rani Mansuri, Arpit Raj, Monika, Anupama Diwan, Eman Shorog, Sabina Yasmin, Sumel Ashique, Md Yousuf Ansari

Molecular Biology Reports · 2025

DOI: 10.1007/s11033-025-11071-4 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Biology Reports, 2025. Verfasst von Rani Mansuri und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Apeejay Stya University, Sohna-Palwal Road, Sohna, Gurgaon, Haryana, 122103, India. ranimansoori@gmail.com. Hauptthemen laut MEDLINE: Vaccination, Nanotechnology, Vaccines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 106 Literaturangaben. Gefördert von: Deanship of Scientific Research, King Khalid University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Seasonal outbreaks of infectious diseases emphasise the critical need for the development of effective vaccines to address global healthcare challenges. Vaccines traditionally evolved using live attenuated organisms, killed organisms, and inactivated toxins. Despite the progression of traditional vaccines, improvement is needed due to toxicity and partial immunogenicity chances after multiple doses. Nanotechnology-based vaccines are now overcoming the gaps in traditional vaccines by enhancing their immunogenicity and reducing levels of toxicity. Nanocarrier-based vaccines reduce dosing frequency by enabling sustained antigen release, thereby minimising the need for booster doses required in conventional vaccines to achieve long-term immunity. The surface of nanocarriers can also be modified by phagocytic cells to increase their uptake for better antigen presentation and recognition and boost antibody production. As a result of better antigen recognition, the antibody production rate of nanocarrier-based vaccines is faster than that of traditional vaccines. Nanocarriers have a distinguished variety of sizes, shapes and compositions. They can also be used for the co-delivery of antigens and adjuvants. These advantageous nanocarriers are classified into various types based on their nature, like polymeric-based, lipid, and inorganic. In the case of solid nanocarriers, they protect against the degradation of the vaccine and improve its facilitation through gut related lymphoid tissues also mucosa linked lymphoid tissue. This review discussed the evolved platform of nanotechnology in vaccine development and its advantages over traditional vaccines. This paper also includes the classification of various nanocarriers, primarily focusing on nanovaccines developed for diseases such as hepatitis, malaria, COVID-19, influenza, human immunodeficiency virus, and cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VaccinationNanotechnologyVaccinesHumansCOVID-19Vaccine DevelopmentNanoparticlesAnimalsDrug CarriersAdjuvants, Immunologic

Stichwörter der Autor:innen

ImmunoresponseNano carriersNanotechnologyNanovaccines delivery

Substanzen

VaccinesDrug CarriersAdjuvants, Immunologic

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Apeejay Stya University, Sohna-Palwal Road, Sohna, Gurgaon, Haryana, 122103, India. ranimansoori@gmail.com.
  • School of Pharmaceutical Sciences, Apeejay Stya University, Sohna-Palwal Road, Sohna, Gurgaon, Haryana, 122103, India.
  • Department of Clinical Pharmacy, College of Pharmacy, King Khalid University, Abha, 62529, Saudi Arabia.
  • Department of Pharmaceutical Chemistry, College of Pharmacy, King Khalid University, Abha, 62529, Saudi Arabia.
  • Department of Pharmaceutical Technology, Bharat Technology, Uluberia, 711316, West Bengal, India.
  • Ibne Seena Pharmacy College, AMES Group of Institutions, Hardoi, Shahabad, 241124, Uttar Pradesh, India. yousufniper@gmail.com.

Förderung

  • Deanship of Scientific Research, King Khalid University

Zitieren

APA

Mansuri, R., Raj, A., Monika, Diwan, A., Shorog, E., Yasmin, S., Ashique, S., & Ansari, M. Y. (2025). Revolutionizing vaccination: the marvel of nanovaccination technology. Molecular Biology Reports. https://doi.org/10.1007/s11033-025-11071-4

Vancouver

Mansuri R, Raj A, Monika, Diwan A, Shorog E, Yasmin S, et al. Revolutionizing vaccination: the marvel of nanovaccination technology. Molecular Biology Reports. 2025. doi:10.1007/s11033-025-11071-4

BibTeX
@article{Mansuri2025,
  author = {Mansuri, Rani and Raj, Arpit and Monika and Diwan, Anupama and Shorog, Eman and Yasmin, Sabina and Ashique, Sumel and Ansari, Md Yousuf},
  title = {Revolutionizing vaccination: the marvel of nanovaccination technology},
  journal = {Molecular Biology Reports},
  year = {2025},
  doi = {10.1007/s11033-025-11071-4}
}
Kostenlos starten →